Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-07 Sale |
2020-12-09 5:11 pm |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
75,000 | $103.4 | $7,755,000 | 2,643,838 (Indirect Direct) |
View |
| 2020-10-16 Purchase |
2020-10-20 8:07 pm |
Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
235,000 | $15 | $3,525,000 | 2,503,903 (Indirect) |
View |
| 2020-09-18 Purchase |
2020-09-22 11:07 am |
Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
230,000 | $13 | $2,990,000 | 158,734 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-12-17 8:08 pm |
N/A N/A |
908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner |
0 | $0 | 5,425,045 (Indirect) |
View |
| 2020-08-18 Other |
2020-12-09 5:11 pm |
N/A N/A |
Twist Bioscience Corp | TWST | CRANDELL KEITH Director |
2,354,322 | $0 | 2,643,838 (Indirect) |
View |
| 2020-11-20 Other |
2020-11-24 8:59 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
831,322 | $0 | 2,058,051 (Indirect) |
View |
| 2020-11-12 Other |
2020-11-16 6:14 pm |
N/A N/A |
Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner |
76,264 | $0 | 1,758,005 (Indirect) |
View |
| 2020-10-16 Conversion |
2020-10-20 8:07 pm |
N/A N/A |
Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
30,658,565 | $0 | 2,503,903 (Indirect) |
View |
Ownership |
2020-10-13 9:23 pm |
N/A N/A |
Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
0 | $0 | 3,620,109 (Indirect) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:12 pm |
N/A N/A |
Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner |
338 | $34.7 | 3,959,756 (Direct) |
View |
| 2020-09-18 Conversion |
2020-09-22 11:07 am |
N/A N/A |
Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
2,710,503 | $0 | 158,734 (Indirect) |
View |
Ownership |
2020-09-15 5:07 pm |
N/A N/A |
Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
0 | $0 | 2,710,503 (Indirect) |
View |